Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.43 by 4.2 percent. This is a 2.76 percent increase over earnings of $1.45 per share from the same period last year. The company reported quarterly sales of $177.76 million which beat the analyst consensus estimate of $171.96 million by 3.37 percent. This is a 22.66 percent increase over sales of $144.92 million the same period last year.